BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 31546700)

  • 1. Siglecs in Brain Function and Neurological Disorders.
    Siddiqui SS; Matar R; Merheb M; Hodeify R; Vazhappilly CG; Marton J; Shamsuddin SA; Al Zouabi H
    Cells; 2019 Sep; 8(10):. PubMed ID: 31546700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
    Angata T; Varki A
    J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
    Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
    Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery, classification, evolution and diversity of Siglecs.
    Angata T; Varki A
    Mol Aspects Med; 2023 Apr; 90():101117. PubMed ID: 35989204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
    Linnartz-Gerlach B; Mathews M; Neumann H
    Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Siglecs, sialic acids and innate immunity.
    Crocker PR; Varki A
    Trends Immunol; 2001 Jun; 22(6):337-42. PubMed ID: 11377294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity ligands of Siglec receptors and their therapeutic potentials.
    Magesh S; Ando H; Tsubata T; Ishida H; Kiso M
    Curr Med Chem; 2011; 18(23):3537-50. PubMed ID: 21756229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
    Angata T; Hingorani R; Varki NM; Varki A
    J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic and clinical immunology of Siglecs.
    von Gunten S; Bochner BS
    Ann N Y Acad Sci; 2008 Nov; 1143():61-82. PubMed ID: 19076345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
    Meyer SJ; Linder AT; Brandl C; Nitschke L
    Front Immunol; 2018; 9():2820. PubMed ID: 30559744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins.
    Brinkman-Van der Linden EC; Varki A
    J Biol Chem; 2000 Mar; 275(12):8625-32. PubMed ID: 10722702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
    Cao H; Crocker PR
    Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Siglecs on autoimmune diseases.
    Brzezicka KA; Paulson JC
    Mol Aspects Med; 2023 Apr; 90():101140. PubMed ID: 36055802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene conversions are frequent but not under positive selection in the Siglec gene families of primates.
    Zid M; Drouin G
    Genome; 2014 Jun; 57(6):317-25. PubMed ID: 25166301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglioside binding pattern of CD33-related siglecs.
    Rapoport E; Mikhalyov I; Zhang J; Crocker P; Bovin N
    Bioorg Med Chem Lett; 2003 Feb; 13(4):675-8. PubMed ID: 12639556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tools to study and target the Siglec-sialic acid axis in cancer.
    Läubli H; Kawanishi K; George Vazhappilly C; Matar R; Merheb M; Sarwar Siddiqui S
    FEBS J; 2021 Nov; 288(21):6206-6225. PubMed ID: 33251699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily.
    Angata T; Varki A
    Glycobiology; 2000 Apr; 10(4):431-8. PubMed ID: 10764831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.
    Freeman S; Birrell HC; D'Alessio K; Erickson-Miller C; Kikly K; Camilleri P
    Eur J Biochem; 2001 Mar; 268(5):1228-37. PubMed ID: 11231274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs.
    Brinkman-Van der Linden EC; Sjoberg ER; Juneja LR; Crocker PR; Varki N; Varki A
    J Biol Chem; 2000 Mar; 275(12):8633-40. PubMed ID: 10722703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.